Shanghai Sanyou Medical Co., Ltd (SHA:688085)

Shanghai Sanyou Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	481.7	451.7	456.91	647.8	592.95	390.35
Other Revenue	1.9	1.9	3.48	1.35	0.41	0.08
Revenue	483.6	453.6	460.39	649.15	593.36	390.43
Revenue Growth (YoY)	25.29%	-1.48%	-29.08%	9.40%	51.98%	10.19%
Cost of Revenue	140.35	145.95	103.81	71.39	63.61	40.27
Gross Profit	343.25	307.65	356.58	577.77	529.75	350.17
Selling, General & Admin	222.25	211.71	193.48	333.64	323.13	205.42
Research & Development	85.13	84.29	65.22	60.38	56.55	33.92
Other Operating Expenses	4.41	4.46	5.07	7.68	6.49	4
Operating Expenses	315.57	301.5	255	404.49	389.04	245.83
Operating Income	27.69	6.14	101.58	173.28	140.71	104.33
Interest Expense	-1.17	-1.17	-0.27	-0.2	-0.16	-
Interest & Investment Income	9.7	13.6	16.25	14.53	34.3	23.66
Currency Exchange Gain (Loss)	-0.74	-0.74	0.32	0.1	-0.17	-0.33
Other Non Operating Income (Expenses)	-1.61	-1.43	-0.31	-0.2	0.19	1.67
EBT Excluding Unusual Items	33.86	16.39	117.58	187.51	174.87	129.33
Impairment of Goodwill	-0.07	-0.07	-	-	-	-
Gain (Loss) on Sale of Investments	3.75	4.16	-6.89	36.32	27.33	-
Gain (Loss) on Sale of Assets	6.39	6.42	-0.05	-0.06	-0.19	-
Asset Writedown	-11.41	-10.13	-	-	-	-
Other Unusual Items	5.13	5.13	24.22	15.78	15.33	7.61
Pretax Income	37.65	21.9	134.87	239.54	217.33	136.95
Income Tax Expense	11.08	9.79	21.23	35.99	22.18	18.39
Earnings From Continuing Operations	26.57	12.11	113.64	203.56	195.15	118.56
Minority Interest in Earnings	-0.18	-0.64	-18.06	-12.74	-8.78	-
Net Income	26.39	11.47	95.58	190.82	186.37	118.56
Net Income to Common	26.39	11.47	95.58	190.82	186.37	118.56
Net Income Growth	-55.15%	-88.00%	-49.91%	2.39%	57.20%	21.20%
Shares Outstanding (Basic)	241	229	252	248	247	228
Shares Outstanding (Diluted)	241	229	252	248	247	228
Shares Change (YoY)	-0.39%	-8.81%	1.50%	0.33%	8.48%	23.11%
EPS (Basic)	0.11	0.05	0.38	0.77	0.75	0.52
EPS (Diluted)	0.11	0.05	0.38	0.77	0.75	0.52
EPS Growth	-54.97%	-86.84%	-50.65%	2.05%	44.90%	-1.55%
Free Cash Flow	13.1	-26.47	241.5	17.78	53.26	47.07
Free Cash Flow Per Share	0.05	-0.12	0.96	0.07	0.22	0.21
Dividend Per Share	0.004	0.004	0.078	0.077	0.150	0.144
Dividend Growth	-94.62%	-94.62%	0.91%	-48.64%	4.66%	-
Gross Margin	70.98%	67.82%	77.45%	89.00%	89.28%	89.69%
Operating Margin	5.73%	1.35%	22.06%	26.69%	23.71%	26.72%
Profit Margin	5.46%	2.53%	20.76%	29.39%	31.41%	30.37%
Free Cash Flow Margin	2.71%	-5.84%	52.45%	2.74%	8.98%	12.06%
EBITDA	59.07	36.41	127.39	188.63	153.9	114.37
EBITDA Margin	12.21%	8.03%	27.67%	29.06%	25.94%	29.29%
D&A For EBITDA	31.38	30.27	25.81	15.35	13.19	10.04
EBIT	27.69	6.14	101.58	173.28	140.71	104.33
EBIT Margin	5.73%	1.35%	22.06%	26.69%	23.71%	26.72%
Effective Tax Rate	29.43%	44.70%	15.74%	15.02%	10.21%	13.43%
Revenue as Reported	483.6	453.6	460.39	649.15	593.36	390.43

Source: S&P Global Market Intelligence. Standard template. Financial Sources.